Myriad Announces Publication of Variant Reclassification Study in the Journal of the American Medical Association - Markets Insider

Myriad Announces Publication of Variant Reclassification Study in the Journal of the American Medical AssociationMarkets InsiderSALT LAKE CITY, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a worldwide leader in personalized medicine, today announced that results from a landmark study of variant classifications following hereditary cancer genetic ...Myriad Announces Publication of Variant Reclassification Study in ...NasdaqMyriad Genetics (MYGN) Announces Publication of Variant ...StreetInsider.comall 20 news articles »